Hope grows for epilepsy patients as clinical trial enters next phase

Phase 2B of the trial is now currently underway and builds on the promising results of earlier testing.

Prof Cook describes it as a very exciting stage that allows them to extend the treatment to much larger groups.

Read the full article on the Saint Vincent's Melbourne website.

Previous
Previous

Cerebral Therapeutics, Inc. Names Guy Anthony as Chief Financial Officer

Next
Next

World-first epilepsy treatment to be rolled out to dozens more patients